Kimelman & Baird’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$8.93M Buy
+65,956
New +$8.67M 0.8% 37
2019
Q3
$9.11M Sell
119,498
-820
-0.7% -$68.1K 1.26% 30
2019
Q2
$10.6M Sell
120,318
-130
-0.1% -$11.1K 1.47% 26
2019
Q1
$10.9M Sell
120,448
-19,100
-14% -$1.62M 1.57% 26
2018
Q4
$10M Sell
139,548
-13,518
-9% -$1.09M 1.56% 27
2018
Q3
$14.7M Buy
153,066
+176
+0.1% +$17.1K 1.85% 24
2018
Q2
$14.6M Buy
+152,890
New +$14.1M 1.91% 21
2017
Q4
$13M Buy
153,015
+320
+0.2% +$26.8K 1.85% 19
2017
Q3
$13.2M Buy
152,695
+80,055
+110% +$6.42M 1.97% 20
2017
Q2
$5.61M Buy
+72,640
New +$5.15M 0.85% 39

Other funds holding XBI